A Study in Advanced Cancers Using Ramucirumab (LY3009806) and Other Targeted Agents

Clinical trial NCT02745769 · COMPLETED

Trial details

NCT number: NCT02745769
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Cancer Colorectal Cancer Mantle Cell Lymphoma

Start date: 2016-10-21
Primary completion: 2018-11-05
Enrollment: 23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.